(Q64188270)
Statements
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis (English)
0 references
27 July 2018
0 references
14 February 2020
0 references
810
0 references
12 year
0 references
75 year
0 references